Bringing Serum Institute of India’s products to Europe

Our parent company, Serum Institute of India, shares our commitment to making vaccines accessible worldwide. Through large-scale production, they have enabled countries that once could not afford vaccines to protect their populations. Today, we bring that strength to Europe—expanding markets where choices have been limited. In 2025, Bilthoven Biologicals introduced the first of these products to the European market.